Posts Tagged ‘Colorado State Board of Pharmacy’
Colorado Board of Pharmacy Update: Non Resident Affidavit
In late 2017, the Colorado Board of Pharmacy (Board) sent notice to all non resident pharmacies licensed with the Board. The notification addressed the distribution of medications into Colorado. In part, the notification stated the following: “Colorado law and Board rule (CRS 12-42.5-118.5 and Board Rules 21.00.20(d)) allow a non resident pharmacy (“Pharmacy”) to distribute…
Read MoreColorado Pharmacists Prescribing Contraceptives Under a New Statewide Protocol
Under a new statewide protocol based on Senate Bill 16-135, only Colorado-licensed pharmacists that have completed an Accreditation Council for Pharmacy Education (ACPE) accredited educational training program related to the prescribing of contraceptives by a pharmacist, may dispense hormonal contraceptive patches and oral hormone contraceptives to patients who are at least 18 years of age. Additionally,…
Read MoreColorado Board of Pharmacy Considering Rule Amendments to Address Medical Board Telehealth Guidelines
As previously discussed on the Baer Law Blog in August, the Colorado Medical Board (Medical Board) adopted Guidelines for the Appropriate Use of Telehealth Technologies in the Practice of Medicine (Guidelines). The Medical Board defined telehealth as: “‘a mode of delivery of health care services through telecommunications systems, including information, electronic, and communication technologies, to…
Read MoreNew Telehealth Guidelines Approved by the Colorado Medical Board: Should Colorado Pharmacists Be Concerned?
The Colorado Medical Board (Board) has adopted Guidelines for the Appropriate Use of Telehealth Technologies in the Practice of Medicine (Guidelines) as the state seeks to enact a new law expanding telehealth services. The Board defines “telehealth” as: ‘a mode of delivery of health care services through telecommunications systems, including information, electronic, and communication technologies, to facilitate…
Read MoreColorado Pharmacy Law: Telehealth and Identifying Valid Preexisting Patient-Practitioner Relationships
The Colorado Medical Board recently published a new draft policy, No. 40-27, on “Guidelines for Appropriate Use of Telehealth Technologies in the Practice of Medicine.” The projected effective date is August 20, 2015. The new guidelines, however, appear to be at odds with the existing Colorado Board of Pharmacy rules that state, in part, the…
Read MoreColorado Pharmacy Reaches HIPAA Settlement
Last month, the U.S. Department of Health and Human Service’s Office for Civil Rights (OCR) announced that Cornell Prescription Pharmacy (Cornell Pharmacy) in Denver, Colorado agreed to settle potential violations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). As part of the settlement, Cornell Pharmacy has agreed to pay a $125,000 penalty…
Read MoreAnalyzing Colorado 2014 Prescription Drug Outlet Disciplinary Actions: Repeated Deficiencies
Baer Law recently completed an analysis of thirty-two (32) separate disciplinary actions against Colorado Prescription Drug Outlets (PDOs) by the Colorado State Board of Pharmacy (Board). The Board registers and licenses pharmacy businesses, both in-state and out-of-state, including: Prescription Drug Outlets; Wholesale distributors of prescription drugs; Manufacturers of prescription drugs; Other outlets; and Limited licenses.…
Read MoreAnalyzing Colorado Pharmacist 2014 Disciplinary Actions: Controlled Substances, Red Flags and Pharmacist Corresponding Responsibility
Baer Law recently completed an analysis of thirty-three (33) separate 2014 disciplinary cases against Colorado pharmacists by the Colorado State Board of Pharmacy (Board). Certain cases, especially those involving controlled substance dispensing errors and pharmacists dispensing controlled substances when no valid patient-prescriber relationship existed, should be of particular interest to all licensed Colorado pharmacists. Out…
Read MoreColorado Pharmacy Legislation Update: Modifying the PDMP
HB14-1283: Modify Prescription Drug Monitoring Program HB14-1283 modifies the electronic prescription drug monitoring as follows: The dissemination of automatic reports to prescribers and pharmacies when a patient meets a defined threshold that takes into account the number of prescribers and pharmacies visited within a certain timeframe. Reports started in September 2014. Allows a prescribing practitioner…
Read MorePharmacists Must Ensure Prescription Orders are Issued for a Legitimate Medical Purpose by an Authorized Prescriber and Have a Recognized Medical Utility or Application
As discussed previously on the Baer Law Blog, corresponding responsibility remains one of the most misunderstood or unknown concepts found in the Drug Enforcement Administration’s (DEA) regulations. The DEA’s regulations (21 CFR 1306.04) regarding corresponding responsibility state: A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an…
Read More